Human immunodeficiency virus type 1 assembly, release, and maturation

Research output: Chapter in Book/Report/Conference proceedingChapter

135 Citations (Scopus)

Abstract

A detailed understanding of human immunodeficiency virus type 1 (HIV-1) assembly, release, and maturation is fundamental to our knowledge of the HIV-1 replication cycle and has the potential to inform the development of new antiretroviral strategies. The structural protein Gag plays a central role in these pathways and drives production of a mature infectious particle through protein–protein, protein–RNA, and protein–lipid interactions. These interactions facilitate multimerization of Gag to form the structural shell of the particle, encapsidation of the RNA genome, trafficking of the virion components to the site of assembly, acquisition of a lipid bilayer and associated envelope glycoproteins, hijacking host cell machinery to facilitate virus release, and proteolytic maturation of the nascent virion. In this review, we describe the significant progress that has been achieved in understanding these processes and highlight key areas that remain unclear. Finally, we discuss how this knowledge is being applied to develop new anti-HIV drugs, an important research priority due to rapid emergence of HIV-1 isolates resistant to currently approved antiretroviral drugs.
Original languageEnglish
Title of host publicationAdvances in Pharmacology (Vol 55), HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms,
EditorsK-T Jeang
PublisherElsevier
Pages347-387
DOIs
Publication statusPublished - 2007

Fingerprint

Dive into the research topics of 'Human immunodeficiency virus type 1 assembly, release, and maturation'. Together they form a unique fingerprint.

Cite this